These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7723357)

  • 1. Exploratory study of the effects of single doses of isomazole on hemodynamics and heart rate variability parameters in chronic heart failure.
    Tuininga YS; van Veldhuisen DJ; Crijns HJ; van den Broek SA; Brouwer J; Haaksma J; Man in 't Veld AJ; Lie KI
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):81-6. PubMed ID: 7723357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrasting preload-dependent hemodynamic and neurohumoral effects of isomazole, a partial phosphodiesterase inhibitor and calcium sensitizer.
    Van der Ent M; Remme WJ; Bartels GL; De Leeuw PW; Van Hoogenhuyze DC; Kruijssen DA
    J Card Fail; 1997 Dec; 3(4):277-86. PubMed ID: 9547442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic and regional hemodynamic effects of isomazole in awake dogs with congestive heart failure.
    Imai N; Liang CS; Stone CK; Hayes JS; Hood WB
    J Pharmacol Exp Ther; 1987 Apr; 241(1):20-6. PubMed ID: 3572783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute hemodynamic effect of oral MDL 17,043 in severe congestive heart failure.
    Uretsky BF; Generalovich T; Reddy PS; Salerni R; Valdes AM; Spangenberg RB; Lang JF; Okerholm RA
    Am J Cardiol; 1984 Aug; 54(3):357-62. PubMed ID: 6235735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute hemodynamic effects and preload-dependent cardiovascular profile of the partial phosphodiesterase inhibitor nanterinone in patients with mild to moderate heart failure.
    Remme WJ; van der Ent M; Bartels GL; van Schelven D; van Hoogenhuyze DC; Krauss XH; Kruijssen HA; Storm CJ
    Cardiovasc Drugs Ther; 1996 May; 10(2):137-44. PubMed ID: 8842505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic effects of the novel selective cAMP-phosphodiesterase III inhibitor R 80122 in anesthetized patients with moderate left ventricular dysfunction before coronary artery bypass grafting.
    Vroom MB; van Wezel HB; Visser CA; Eijsman L; van Zwieten PA
    J Cardiothorac Vasc Anesth; 1995 Jun; 9(3):272-7. PubMed ID: 7669959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of isomazole on force of contraction and phosphodiesterase isoenzymes I-IV in nonfailing and failing human hearts.
    Bethke T; Klimkiewicz A; Kohl C; von der Leyen H; Mehl H; Mende U; Meyer W; Neumann J; Schmitz W; Scholz H
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):386-97. PubMed ID: 1720839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic, neurohumoral, and myocardial energetic effects of pimobendan, a novel calcium-sensitizing compound, in patients with mild to moderate heart failure.
    Remme WJ; Kruijssen DA; van Hoogenhuyze DC; Krauss XH; Bartels GL; Storm CJ; de Leeuw PW
    J Cardiovasc Pharmacol; 1994 Nov; 24(5):730-9. PubMed ID: 7532750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDL 17,043: short- and long-term cardiopulmonary and clinical effects in patients with heart failure.
    Rubin SA; Tabak L
    J Am Coll Cardiol; 1985 Jun; 5(6):1422-7. PubMed ID: 3158690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The electrophysiologic effects of enoximone in patients with preexisting ventricular tachyarrhythmias.
    Miles WM; Heger JJ; Minardo JD; Klein LS; Prystowsky EN; Zipes DP
    Am Heart J; 1989 Jan; 117(1):112-21. PubMed ID: 2521415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of phosphodiesterase inhibitors to adrenergic agents in acutely ill patients.
    Vincent JL; Léon M; Berré J; Mélot C; Kahn RJ
    Int J Cardiol; 1990 Jul; 28 Suppl 1():S7-11. PubMed ID: 2145239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial energetics and clinical response to the cardiotonic agent MDL 17043 in advanced heart failure.
    Martin JL; Likoff MJ; Janicki JS; Laskey WK; Hirshfeld JW; Weber KT
    J Am Coll Cardiol; 1984 Nov; 4(5):875-83. PubMed ID: 6238075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sulmazole: a new positive inotropic agent].
    Renard M; Jacobs P; Melot C; Dresse A; Bernard R
    Ann Cardiol Angeiol (Paris); 1984; 33(4):219-22. PubMed ID: 6465815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure.
    Maskin CS; Sinoway L; Chadwick B; Sonnenblick EH; Le Jemtel TH
    Circulation; 1983 May; 67(5):1065-70. PubMed ID: 6831672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic effects of a new inotropic agent, piroximone (MDL 19205), in patients with chronic heart failure.
    Petein M; Levine TB; Cohn JN
    J Am Coll Cardiol; 1984 Aug; 4(2):364-71. PubMed ID: 6736478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Method specificity of the auscultatory estimates of the inodilatory reduction of diastolic blood pressure based on Korotkoff IV and V criteria.
    De Mey C
    Br J Clin Pharmacol; 1995 May; 39(5):485-90. PubMed ID: 7669483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of low doses of amrinone to produce sustained hemodynamic improvement in patients with severe chronic congestive heart failure.
    Packer M; Medina N; Yushak M
    Am J Cardiol; 1984 Nov; 54(8):1025-9. PubMed ID: 6496324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous and oral MDL 17043 (a new inotrope-vasodilator agent) in congestive heart failure: hemodynamic and clinical evaluation in 38 patients.
    Kereiakes D; Chatterjee K; Parmley WW; Atherton B; Curran D; Kereiakes A; Spangenberg R
    J Am Coll Cardiol; 1984 Nov; 4(5):884-9. PubMed ID: 6238076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute effect of enoximone and captopril in patients with heart failure].
    Scholz M; Kneissl GD; Dieterich HA; Kaltenbach M; Bussmann WD
    Z Kardiol; 1991; 80 Suppl 4():69-74. PubMed ID: 1833901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of R80122. The influence of a new phosphodiesterase inhibitor on global and intestinal hemodynamics in coronary surgery patients].
    Lange H; Stephan H; Autschbach R; Lueerssen K; Zielmann S; Sonntag H
    Anaesthesist; 1992 Aug; 41(8):474-80. PubMed ID: 1524159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.